A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.

Fonte: Business Insider

Matt Kaeberlein, the CEO of Optispan, shared his longevity habits. Matt KaeberleinMatt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels tested in his 50s and gradually began testosterone replacement therapy (TRT).